Gregory M. Weinhoff - May 27, 2021 Form 3/A - Amendment Insider Report for Centessa Pharmaceuticals plc (CNTA)

Signature
/s/ Marella Thorell, attorney-in-fact
Stock symbol
CNTA
Transactions as of
May 27, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
6/4/2021, 04:45 PM
Date Of Original Report
May 27, 2021
Next filing
Jun 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTA Share Option (right to buy) May 27, 2021 Ordinary Shares 639K $5.84 Direct F1, F2, F3
holding CNTA Share Option (right to buy) May 27, 2021 Ordinary Shares 320K $5.84 See footnote F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option shall vest and become exercisable on March 1, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
F2 Represents A Ordinary Shares that were redesignated as Ordinary Shares immediately prior to the closing of the initial public offering.
F3 Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F4 Held by Gregory Weinhoff 2017 Trust, a spousal lifetime access trust ("SLAT"), of which the Reporting Person's spouse and another immediate family member are trustees. The beneficiaries of the SLAT are the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of the securities held by the SLAT.

Remarks:

This amendment is being filed to disclose that options to purchase up to 319,660 ordinary shares are held by the SLAT rather than by the Reporting Person in his direct capacity. No other modifications to the original Form 3 filed on May 27, 2021 are being made hereby.